KATELYN PIKE: Open Payments
NPI 1396410866 · DEATSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$922 in 38 payments from 13 companies in 2025. Trend: 2023 $738 · 2024 $1,631 · 2025 $922
Food & beverage: $922
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 7 | $197 |
| Novo Nordisk Inc | 6 | $136 |
| Amgen Inc. | 6 | $135 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $116 |
| Novartis Pharmaceuticals Corporation | 3 | $86 |
| Ardelyx, Inc. | 2 | $50 |
| OPKO Pharmaceuticals, LLC | 2 | $44 |
| Fresenius USA Marketing, Inc. | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $32 |
| AKEBIA THERAPEUTICS INC | 1 | $29 |
Products named: TARPEYO, KRYSTEXXA, Kerendia, Fabhalta, Ozempic, Rybelsus, IBSRELA, RAYALDEE.
Industry payments across AL — which companies pay providers there.
